Despite the limitations/challenges mentioned above, a clear understanding of the molecular profile of TEX and the intricate crosstalks between TEX and immune cells in a tumor microenvironment may lead to effective personalized immunotherapy to improve clinical outcomes. Here, TEX46 is linked to neoplasm.